<b>Background/Objectives:</b><i>SLC13A5</i> encodes a sodium-citrate cotransporter implicated in early-onset epileptic encephalopathy and metabolic brain dysfunction, yet its developmental regulation and molecular context in the human brain remain incompletely defined. The gene discussed is SLC13A5; the disease is Epileptic encephalopathy.